Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21050493rdf:typepubmed:Citationlld:pubmed
pubmed-article:21050493lifeskim:mentionsumls-concept:C0012655lld:lifeskim
pubmed-article:21050493lifeskim:mentionsumls-concept:C0339143lld:lifeskim
pubmed-article:21050493lifeskim:mentionsumls-concept:C0670896lld:lifeskim
pubmed-article:21050493lifeskim:mentionsumls-concept:C0086582lld:lifeskim
pubmed-article:21050493lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:21050493lifeskim:mentionsumls-concept:C1335671lld:lifeskim
pubmed-article:21050493lifeskim:mentionsumls-concept:C0678951lld:lifeskim
pubmed-article:21050493lifeskim:mentionsumls-concept:C0039260lld:lifeskim
pubmed-article:21050493pubmed:dateCreated2010-11-29lld:pubmed
pubmed-article:21050493pubmed:abstractTextToll-like receptors (TLRs) are a family of pattern-recognition receptors, which plays a role in eliciting innate/adaptive immune responses and developing chronic inflammation. The polymorphisms of TLRs have been associated with the risk of various autoimmune diseases, including systemic lupus erythematosus (SLE), multiple sclerosis and rheumatorid arthritis. The aim of this study was to evaluate whether TLR genes could be used as genetic markers for the development of Graves' ophthalmopathy (GO).lld:pubmed
pubmed-article:21050493pubmed:languageenglld:pubmed
pubmed-article:21050493pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21050493pubmed:citationSubsetIMlld:pubmed
pubmed-article:21050493pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21050493pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21050493pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21050493pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21050493pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21050493pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21050493pubmed:statusMEDLINElld:pubmed
pubmed-article:21050493pubmed:issn1471-2350lld:pubmed
pubmed-article:21050493pubmed:authorpubmed-author:T'uS CSClld:pubmed
pubmed-article:21050493pubmed:authorpubmed-author:TsaiFuu-JenFJlld:pubmed
pubmed-article:21050493pubmed:authorpubmed-author:ChenWen-ChiWClld:pubmed
pubmed-article:21050493pubmed:authorpubmed-author:LinHui-JuHJlld:pubmed
pubmed-article:21050493pubmed:authorpubmed-author:ChenRong-Hsin...lld:pubmed
pubmed-article:21050493pubmed:authorpubmed-author:TsaiYuhsinYlld:pubmed
pubmed-article:21050493pubmed:authorpubmed-author:LiaoWen-LingW...lld:pubmed
pubmed-article:21050493pubmed:authorpubmed-author:LiuYu-HueiYHlld:pubmed
pubmed-article:21050493pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21050493pubmed:volume11lld:pubmed
pubmed-article:21050493pubmed:ownerNLMlld:pubmed
pubmed-article:21050493pubmed:authorsCompleteYlld:pubmed
pubmed-article:21050493pubmed:pagination154lld:pubmed
pubmed-article:21050493pubmed:meshHeadingpubmed-meshheading:21050493...lld:pubmed
pubmed-article:21050493pubmed:meshHeadingpubmed-meshheading:21050493...lld:pubmed
pubmed-article:21050493pubmed:meshHeadingpubmed-meshheading:21050493...lld:pubmed
pubmed-article:21050493pubmed:meshHeadingpubmed-meshheading:21050493...lld:pubmed
pubmed-article:21050493pubmed:meshHeadingpubmed-meshheading:21050493...lld:pubmed
pubmed-article:21050493pubmed:meshHeadingpubmed-meshheading:21050493...lld:pubmed
pubmed-article:21050493pubmed:meshHeadingpubmed-meshheading:21050493...lld:pubmed
pubmed-article:21050493pubmed:meshHeadingpubmed-meshheading:21050493...lld:pubmed
pubmed-article:21050493pubmed:meshHeadingpubmed-meshheading:21050493...lld:pubmed
pubmed-article:21050493pubmed:meshHeadingpubmed-meshheading:21050493...lld:pubmed
pubmed-article:21050493pubmed:meshHeadingpubmed-meshheading:21050493...lld:pubmed
pubmed-article:21050493pubmed:meshHeadingpubmed-meshheading:21050493...lld:pubmed
pubmed-article:21050493pubmed:meshHeadingpubmed-meshheading:21050493...lld:pubmed
pubmed-article:21050493pubmed:meshHeadingpubmed-meshheading:21050493...lld:pubmed
pubmed-article:21050493pubmed:meshHeadingpubmed-meshheading:21050493...lld:pubmed
pubmed-article:21050493pubmed:meshHeadingpubmed-meshheading:21050493...lld:pubmed
pubmed-article:21050493pubmed:meshHeadingpubmed-meshheading:21050493...lld:pubmed
pubmed-article:21050493pubmed:meshHeadingpubmed-meshheading:21050493...lld:pubmed
pubmed-article:21050493pubmed:year2010lld:pubmed
pubmed-article:21050493pubmed:articleTitleToll-like receptor gene polymorphisms are associated with susceptibility to Graves' ophthalmopathy in Taiwan males.lld:pubmed
pubmed-article:21050493pubmed:affiliationGenetic Center, China Medical University Hospital, Taichung, Taiwan.lld:pubmed
pubmed-article:21050493pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21050493pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:7099entrezgene:pubmedpubmed-article:21050493lld:entrezgene
entrez-gene:54106entrezgene:pubmedpubmed-article:21050493lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21050493lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21050493lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21050493lld:entrezgene